Christopher Heeschen
14Patents
5h-index
14Co-inventors
59Inventor score
Filing activity: Jul 28, 2000 → Sep 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6417205B1 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 52 | Expired |
| US6720340B1 | Nicotine receptor agonists in stem cell and progenitor cell recruitment | Human Necessities | 27 | Expired |
| US7598275B2 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 15 | Active |
| US7045534B2 | Methods of reducing angiogenesis | Human Necessities | 10 | Expired |
| US8188043B2 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 10 | Active |
| US7919315B2 | In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (BMPS) and/or blood-derived circulating precursor cells (BDPS) | Physics | 5 | Active |
| US8409815B2 | sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases | Physics | 4 | Expired |
| US7390821B2 | Methods of reducing angiogenesis | Human Necessities | 3 | Expired |
| US7652038B2 | Methods of reducing angiogenesis | Human Necessities | 2 | Active |
| US8673581B2 | sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases | Physics | 0 | Active |
| US8309608B2 | Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases | Human Necessities | 0 | Active |
| US8163780B2 | Nicotine receptor agonists in stem cell and progenitor cell recruitment | Human Necessities | 0 | Active |
| US7838539B2 | Nicotine receptor agonists in stem cell and progenitor cell recruitment | Human Necessities | 0 | Active |
| US9060915B2 | Methods for improving cell therapy and tissue regeneration in patients with cardiovascular diseases by means of shockwaves | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.